Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Targeted NO donor enhances the activity of aspirin and heparin in preventing embolization

June 8, 1998

Avigen and Cell Genesys report success with gene therapy of hemophilia B

June 2, 1998

Emisphere Technologies begins phase II trial with oral heparin

June 1, 1998

Integrilin launched in first market today

June 1, 1998

Schering AG presents factor Xa/thrombin inhibitors

June 1, 1998

New antiplatelet agents prepared by Sankyo/Ube researchers

May 29, 1998

P2T purinoceptor receptor antagonists with platelet antiaggregatory activity

May 28, 1998

First launch for Aggrastat, a new antiplatelet agent for acute coronary syndrome

May 26, 1998

FDA approves Aggrastat, the first platelet blocker for unstable angina

May 22, 1998

BLA and MAA filed for recombinant factor VIII product for hemophilia A

May 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...